Sweden· SE-20110923000033
Xifaxan 550 mg Filmdragerad tablett
A medicinal product containing rifaximin, registered in Sweden by Norgine BV.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Rifaximin
- Manufacturer
- Norgine BV
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20110923000033
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Rifaximin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandReferoALFASIGMA S.p.A.
- NetherlandsTIXTELLER 550 mg filmomhulde tablettenAlfasigma S.p.A.
- BelgiumTargaxan 550 mgNorgine
- NorwayRifaximin Aurora Medical2care4 ApS
- IrelandRifaximin Alfasigma 550 mg film-coated tabletsAlfasigma S.p.A
- SwitzerlandXifaxan 550 mg, FilmtablettenAlfasigma Schweiz AG
- SpainTIXTAR 550 MG COMPRIMIDOS RECUBIERTOS CON PELICULAAlfasigma S.P.A.
- PolandTixtellerAlfasigma S.p.A.
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Colidimin, Refero
- Belgium · Targaxan, Tixteller
- Czechia · Normix
- Germany · Rifaxan, Tixteller
- Denmark · Faxinorm, Xifaxan
- Spain · Spiraxin, Tixtar
- Finland · Targaxan, Xifaxan
- France · Tixtar
- United Kingdom (Northern Ireland) · Normicron, Rifaximin
- Greece · Rifacol
- Hungary · Normix, Refero
- Ireland · Rifaximin Alfasigma, Targaxan
- Italy · Flonorm, Normix
- Luxembourg · Refero, Targaxan
- Netherlands · Tixteller, Xifaxan
- Norway · Xifaxan
- Poland · Tixteller, Xifaxan
- Portugal · Refero, Xifaxan
- Romania · Normix, Tixteller
- Slovakia · Normix, Refero
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/47bf9fe0-6cbd-42de-8143-85316e155995 GET /v1/drugs/47bf9fe0-6cbd-42de-8143-85316e155995?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL"
],
"se_npl_id": "20110923000033",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20110923000033",
"product_doc_link": "https://docetp.mpa.se/LMF/Xifaxan%20film-coated%20tablet%20SmPC_09001bee807a823f.pdf"
}See everything about rifaximin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.